Kyle Hutchinson

Avails Medical, Inc. is a pioneer in rapid, automated solutions for antibiotic susceptibility testing (AST). Founded by a team of Stanford postdoctoral researchers, Avails’ electronic biosensor technology is designed to improve affordability and speed in pathogen quantification and susceptibility testing directly from human specimens for clinical laboratories by eliminating manual, time-consuming culturing steps. Avails’ eQUANT(TM) platform enables microbiology labs to generate an automated 0.5 McFarland equivalent (eMcF) directly from positive blood cultures (PBC), removing as many as 18+ hours from the standard workflow by eliminating the need for subcultures. The eQUANT system is FDA 510(k) cleared. IN DEVELOPMENT: Avails is also developing a rapid phenotypic AST platform being designed for use directly from PBCs as well as cultured isolates. Avails electrical biosensor platform fits within the laboratorys existing workflow and budget, serving clinical labs in smaller community hospitals to larger academic centers and centralized laboratories.

Avive Solutions, Inc. is a Bay Area-based venture-backed MedTech company that has developed an award winning next-generation automated external defibrillator (AED) and software solutions in an effort to significantly increase survival rates from Sudden Cardiac Arrest. We are FDA-approved and the only AED in the industry that alerts 911. Join us on our journey to save lives.

Lateral Investment Management is a private equity firm focused exclusively on investing in founder-owned companies that have reached an inflection point. We partner with high conviction owners who want an institutional partner to help them expand and accelerate their vision. At Lateral, we take a collaborative approach that leverages our domain expertise, strategic insight, and operational resources to drive significant growth and value creation. We specialize in technology and business services, specifically B2B software, industrial technology, managed solutions, and technology-enabled services. Lateral Investment Management, LLC is an SEC Registered Investment Advisor and a minority owned firm.

K1 is one of the largest investors in small-cap AI-powered software. Dedicated to transforming lives and industries by building category leaders in technology, K1 has invested in over 275 companies since inception. Headquartered in Manhattan Beach, California, the firm partners early with founders and management teams to build AI-powered, mission-critical systems of record for enterprise clients globally.

Avails Medical, Inc. is a pioneer in rapid, automated solutions for antibiotic susceptibility testing (AST). Founded by a team of Stanford postdoctoral researchers, Avails’ electronic biosensor technology is designed to improve affordability and speed in pathogen quantification and susceptibility testing directly from human specimens for clinical laboratories by eliminating manual, time-consuming culturing steps. Avails’ eQUANT(TM) platform enables microbiology labs to generate an automated 0.5 McFarland equivalent (eMcF) directly from positive blood cultures (PBC), removing as many as 18+ hours from the standard workflow by eliminating the need for subcultures. The eQUANT system is FDA 510(k) cleared. IN DEVELOPMENT: Avails is also developing a rapid phenotypic AST platform being designed for use directly from PBCs as well as cultured isolates. Avails electrical biosensor platform fits within the laboratorys existing workflow and budget, serving clinical labs in smaller community hospitals to larger academic centers and centralized laboratories.

Avive Solutions, Inc. is a Bay Area-based venture-backed MedTech company that has developed an award winning next-generation automated external defibrillator (AED) and software solutions in an effort to significantly increase survival rates from Sudden Cardiac Arrest. We are FDA-approved and the only AED in the industry that alerts 911. Join us on our journey to save lives.

Franklin Resources, Inc. [NYSE:BEN] is a global investment management organization with subsidiaries operating as Franklin Templeton (www.franklinresources.com). The products, services, information and materials referenced in this site may not be available to residents in certain jurisdictions. Consult with an investment professional or contact your local Franklin Templeton office for more information. This site and the information contained herein is not intended to constitute an offer to sell or an invitation or solicitation of an offer to buy any product or service by Franklin Templeton. Nothing in this website should be construed as investment, tax, legal or other advice. All investments involve risks, including potential loss of principal. LinkedIn is owned by a third party unaffiliated with us. We are not responsible for LinkedIn’s privacy, security, or terms of use policies that control this service, nor their content, software, or tools (or those of any third party’s) that are available through links from this page. You use any third-party site/media, software and materials at your own risk. US readers: View our Terms and Conditions at: https://www.franklinresources.com/resources/social ©Franklin Templeton. All rights reserved.